Professor, Internal Medicine, University of Nebraska Medical Center College of Medicine
Hematology
Dr. James O. Armitage, MD
|
|
Give Review
James O. Armitage works in the field of Hematology. He researched medicine at University of Nebraska Medical Center. University of Nebraska Medical Center is a one of the best medicals schools. University of Nebraska Medical Center is ranked 60 in research and 4 in primary care medicine He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FASCO)". Dr. James O. Armitage has written publications. He has 100 publications published with PubMed. The lastest paper is: 'Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project.'
Publications
- Relative frequency of non-Hodgkin Lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.
- Non-Hodgkin Lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project.
- Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
- Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based Analysis.
- Non-Hodgkin Lymphoma in the Far East: review of 730 cases from the international non-Hodgkin Lymphoma classification project.
- Autologous and allogeneic hematopoietic stem cell transplantation in follicular Lymphoma.
- Classification of non-Hodgkin Lymphoma in South-eastern Europe: review of 632 cases from the international non-Hodgkin Lymphoma classification project.
- Leukemic diffuse large B-cell Lymphoma in a patient with myeloproliferative disorder.
- Clinicopathologic features and management of blastoid variant of mantle cell Lymphoma.
- Mortality Patterns Among Recipients of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma in the Past Three Decades.
- Utility of prechemotherapy evaluation of left ventricular function for patients with Lymphoma.
- Regulatory and clinical considerations for biosimilar oncology drugs.
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggresive B-cell Lymphoma.
- Estimating the State-Level Supply of Cancer Care Providers: Preparing to Meet Workforce Needs in the Wake of Health Care Reform.
- Allogeneic stem cell transplantation for Philadelphia chromosome-positive Acute myeloid leukemia.
- Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care.
- Limited utility of routine surveillance imaging for classical hodgkin Lymphoma patients in first complete remission.
- Gene expression signatures delineate biologic and prognostic subgroups in peripheral T-cell Lymphoma.
- Increasing complexity of high-grade B-cell Lymphomas.
- Phase I/II Study of Bortezomib-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Indolent Non-Hodgkin Lymphoma, Transformed, or Mantle Cell Lymp...
- The aggressive peripheral T-cell Lymphomas: 2013.
- Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in Lymphoma patients.
- Who benefits from surveillance imaging in Lymphoma?
- Announcing a new series: Understanding unusual dysproteinemias.
- Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for hodgkin Lymphoma.
- Does functional imaging distinguish nodular lymphocyte-predominant hodgkin Lymphoma from T-cell/histiocyte-rich large B-cell Lymphoma?
- Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium After Doxorubicin-based Chemotherapy.
- B-cell Lymphoma, unclassifiable, with features intermediate between diffuse large B-cell Lymphoma and burkitt Lymphoma: study of 39 cases.
- Is there a role for autotransplants in patients with follicular Lymphoma in the rituximab era?
- Fondaparinux-associated heparin-induced thrombocytopenia.
- CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell Lymphoma.
- Colony-stimulating factors for febrile neutropenia during Cancer therapy.
- Phase II trial of 131-Iodine toSitumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.
- Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT).
- A new look at an old Syndrome.
- Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.
- Who Benefits From Surveillance Imaging?
- The aggressive peripheral T-cell Lymphomas: 2012 update on diagnosis, risk stratification, and management.
- Genome-wide MicroRNA profiling of mantle cell Lymphoma reveal a distinct subgroup with poor prognosis.
- The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell Lymphomas: A study of 826 cases from the International Peripheral T-cell Lymp...
- The addition of rituximab reduces the incidence of secondary central Nervous system involvement in patients with diffuse large B-cell lymphoma.
- Sarcoidosis mimicking recurrent Lymphoma.
- Transplantation for Lymphoma: Good for the Brain as Well as the Body?
- Non-Hodgkin Lymphoma of the prostate.
- Cell of origin fails to predict survival in patients with diffuse large B-cell Lymphoma treated with autologous hematopoietic stem cell transplantation.
- BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-Cell Lymphoma Treated with CHOP-like therapy and Rituximab.
- PET scans: when and how?
- The Importance of Testing PET-Directed Therapy in Patients with Hodgkin Lymphoma.
- Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization System.
- High-dose therapy/autologous hematopoietic stem cell transplantation in relapsed or refractory marginal zone non-Hodgkin Lymphoma.
- Enteropathy-associated T-cell Lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project.
- Restrospective on the last quarter-century in hematologic oncology.
- The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin Lymphoma.
- A decade of progress in Lymphoma: advances and continuing challenges.
- Clinical roundtable monograph. T-cell Lymphoma: therapeutic overview and disease state awareness.
- Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents.
- Early-stage Hodgkin's Lymphoma.
- Genomic Analysis of lymphoma: potential for clinical application.
- Reassessments of ESAs for Cancer treatment in the US and Europe.
- Peripheral T-cell Lymphomas: their time has come.
- Survival disparities in patients with Lymphoma according to place of residence and treatment provider: a population-based study.
- No advantage for chlorambucil maintenance therapy in gastric MALT Lymphoma.
- Looking back (and ahead) at salvage treatment for non-Hodgkin Lymphoma.
- Salvage therapy for Hodgkin's Lymphoma.
- Adult Burkitt Lymphoma: advances in diagnosis and treatment.
- Hodgkin Lymphoma and the impact of age.
- Stromal gene signatures in large-B-cell Lymphomas.
- Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-Cell-like and non-germinal center B-Cell-like subtypes of diffuse la...
- Acute coronary syndromes complicating the first infusion of rituximab.
- Professionalism and Cancer care.
- Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin Lymphoma: effect of histological grade and Follicular International Prognostic In...
- Outcomes after hematopoietic stem-Cell transplantation for hematologic malignancies in patients with or without advance care planning.
- ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic Leukemia.
- How I treat patients with diffuse large B-cell Lymphoma.
- Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
- Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic Leukemia patients irrespective of 11q23 deletion.
- 2006 update of recommendations for the use of white blood Cell growth factors: an evidence-based clinical practice guideline.
- Acute radiation injury: contingency planning for triage, supportive care, and transplantation.
- Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell Lymphoma.
- Prospective study of survival outcomes in Non-Hodgkin's Lymphoma patients with rheumatoid arthritis.
- Management of Hodgkin Lymphoma.
- Lymphoma 2006: classification and treatment.
- BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell Lymphoma.
- Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell Lymphoma.
- Staging non-Hodgkin Lymphoma.
- Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell Lymphoma.
- Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS Syndrome.
- Prognostic factors of chronic Graft-versus-host disease after allogeneic blood stem-cell transplantation.
- The treatment of patients with aggressive non-Hodgkin's Lymphoma.
- Defining the stages of aggressive non-Hodgkin's Lymphoma--a work in progress.
- Follicular Lymphoma: expanding therapeutic options.
- Phase I trial of iodine-131 toSitumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma.
- Prediction of survival in follicular Lymphoma based on molecular features of tumor-infiltrating immune cells.
- Prognostic factors influencing survival in patients with B-cell small lymphocytic Lymphoma.
- BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell Lymphoma.
- Treatment of indolent non-Hodgkin's Lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone.
- Advances in follicular Lymphoma.
- Autologous transplantation for diffuse aggressive non-Hodgkin Lymphoma in first relapse or second remission.
- Use of erythropoietin in Cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
Schools
University of Nebraska College of Medicine
University Nebr Med Center
University Ia Hosps
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FASCO)
Education
-
University of Iowa Hospitals and Clinics -
University of Nebraska Medical Center -
University of Nebraska College of Medicine
Drug Facts
| NPI NUMBER | 1073579090 | |
| NPPES Provider LastName | ARMITAGE | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 681988102 | |
| NPPES Provider State | NE | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 214.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073579090 |
| Last Name Of The Provider | ARMITAGE |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Kari L. Cunningham, APRN |
|
|
Danielle L. Geiger, APRN |
|
|
Christina L. Holmes, ARNP |
|
|
Margaret J. Rebensdorf, APRN
 This Doctor is OpenDoctor Recommended.
|
|
|
Sheryl P. Shannon, APRN
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean L. Grem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie M. Vose, MD |
|
|
Dr. Kenneth H. Cowan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gamini S. Soori, MD |
|
|
Dr. Elizabeth C. Reed, MD |
|
Dr. Luke T. Nordquist, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Krishna Gundabolu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter F. Coccia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip J. Bierman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole A. Shonka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maureen G. Conlan, MD |
|
|
Dr. Herbert A. Hartman Jr., MD |
|
|
Dr. Marcel P. Devetten, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew A. Lunning, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret A. Kessinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadiq U. Zaman, MD
This Doctor is OpenDoctor Recommended.
|